Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
Robin Foà(Institute of Oncology Research), Francesca Paoloni(Fondazione Gimema Onlus), Mario Luppi(University of Modena and Reggio Emilia), Claudio Fozza(University of Sassari), Eliana Zuffa(Ospedale "Santa Maria delle Croci" di Ravenna), Simona Soverini(University of Bologna), Paola Fazi(San Antonio College), Giuseppe Cimino(Sapienza University of Rome), Francesco Nobile(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Felicetto Ferrara(San Antonio College), Michele Baccarani(University of Bologna), Anna Guarini(Sapienza University of Rome), Ilaria Iacobucci(Policlinico S.Orsola-Malpighi), Giovanna Meloni(Sapienza University of Rome), Simona Sica(San Antonio College), Giovanni Martinelli(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Marco Vignetti(San Antonio College), Carlo Castagnola(University of Pavia), Antonella Vitale(Sapienza University of Rome), Franco Mandelli(San Antonio College), Pietro Leoni(Azienda Ospedaliero-Universitaria delle Marche), Maria Stefania De Propris(Sapienza University of Rome), Anna Candoni(University of Udine), Loredana Elia(Sapienza University of Rome)
Cited by 460
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644